Severe Group A Streptococcal Infections
- PMID: 26866227
- Bookshelf ID: NBK333425
Severe Group A Streptococcal Infections
Excerpt
Life-threatening infections caused by Streptococcus pyogenes (group A streptococcus) include scarlet fever, bacteremia, pneumonia, necrotizing fasciitis, myonecrosis and Streptococcal Toxic Shock Syndrome (StrepTSS). This chapter focuses on the clinical and epidemiological features of these infections, as well as treatment options and bacterial pathogenesis. In brief, such invasive infections can simply be defined as any infection in which S. pyogenes is isolated from a normally sterile body site. Patients with invasive S. pyogenes infections have a relatively low mortality rate, unless they meet the established criteria for StrepTSS.
Patient mortality is also influenced by the site of infection and the patient’s presenting history. For example, in patients with S. pyogenes necrotizing fasciitis/myonecrosis that lacks a discernable portal of bacterial entry, classical cutaneous signs of a necrotizing process are not initially apparent. In the absence of such clinical clues, the correct diagnosis is often missed or delayed until the patient manifests systemic shock and organ failure. This delay results in high morbidity and mortality rates. Interestingly, patients in this “no portal” category frequently develop soft-tissue infection at a site of relatively minor antecedent soft tissue injury (strain, bruise) that did not break the skin. Pain at the time of presentation is often out of proportion to the injury itself, and is an important clinical clue. A molecular mechanism that links injury to secondary S. pyogenes infection has been recently proposed, and is discussed later in this chapter.
Development of severe invasive infections is associated with strains that produce streptococcal pyrogenic exotoxins (Spe)—a family of bacterial superantigens that includes the classical scarlatina toxins SpeA and SpeC, the cysteine proteinase SpeB, and a number of more recently described superantigens (such as mitogenic factor [MF, SpeF] and streptococcal superantigen [SSA]). Superantigens are potent immunostimulators that cause clonal proliferation of T cells and watershed production of pro-inflammatory cytokines that mediate shock and organ failure. This concept, as well as the molecular biology of streptococcal virulence, colonization, and tissue invasion, is discussed in more detail in the section on the pathogenesis of StrepTSS.
© The University of Oklahoma Health Sciences Center.
Sections
Similar articles
-
Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins).J Immunol. 1993 Mar 15;150(6):2457-66. J Immunol. 1993. PMID: 8450222
-
Streptococcus pyogenes Impetigo, Erysipelas, and Cellulitis.2022 Sep 7 [updated 2022 Oct 4]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 23. 2022 Sep 7 [updated 2022 Oct 4]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 23. PMID: 36479753 Free Books & Documents. Review.
-
Impetigo, Erysipelas and Cellulitis.2016 Feb 10. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016–. 2016 Feb 10. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016–. PMID: 26866211 Free Books & Documents. Review.
-
Molecular analysis of the role of streptococcal pyrogenic Exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes.Mol Microbiol. 1999 Aug;33(4):778-90. doi: 10.1046/j.1365-2958.1999.01525.x. Mol Microbiol. 1999. PMID: 10447887
-
[Clinical aspects of streptococcal and staphylococcal toxinic diseases].Arch Pediatr. 2001 Sep;8 Suppl 4:762s-768s. doi: 10.1016/s0929-693x(01)80194-9. Arch Pediatr. 2001. PMID: 11582925 Review. French.
References
-
- Adams E. M., Gudmundsson S., Yocum D. E., Haselby R. C., Craig W. A., Sundstrom W. R. Streptococcal myositis. Archives of Internal Medicine. 1985;145(6):1020–1023. - PubMed
-
- Aronoff D. M., Bloch K. C. Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore) 2003;82(4):225–235. - PubMed
-
- Aziz R. K., Pabst M. J., Jeng A., Kansal R., Low D. E., Nizet V., et al. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Molecular Microbiology. 2004;51(1):123–134. - PubMed
-
- Baddour L. M. Infective endocarditis caused by beta-hemolytic streptococci. Clinical Infectious Diseases. 1998;26(1):66–71. - PubMed
-
- Barnham M. Invasive streptococcal infections in the era before the acquired immune deficiency syndrome: A 10 years' compilation of patients with streptococcal bacteraemia in North Yorkshire. The Journal of Infection. 1989;18(3):231–248. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials